Information Links
Previous Issues Volume 7, Issue 2 - 2023
Use of Mesenchymal Stem Cells in Corneal Ulcers in Dogs: A Case Report
Perla Palafox-Herrera1, Yomira N Ortiz-Avilez1, Ramón Ruelas-Aviles2, Daniela Ruelas-Vogel2, Diana Mosco-Fierro2, Darien Mesa-Diaz2, Selem Torres1,3, Miguel Ramirez-Amezcua1,3, Diana Esquivel1,3,4,*
1PetCell, Mexico
2Instituto de Terapia Celular (ITC), Mexico
3Central Medica Veterinaria, Mexico
4Global Institute of Stem Cell and Research, Mexico
*Corresponding author: M.Sc. Diana Esquivel, Head of the laboratories of GIOSTAR, Mexico; E-mail: [email protected].
Received Date: April 14, 2023
Published Date: May 02, 2023
Citation: Esquivel D, et al. (2023). Use of Mesenchymal Stem Cells in Corneal Ulcers in Dogs: A Case Report. Mathews J Vet Sci. 7(1):20.
Copyrights: Esquivel D, et al. © (2023).
ABSTRACT
The development and complication of corneal ulcers (CU) in dogs has become a serious burden in pet health. Dogs with exaggerated juvenile-like craniofacial conformations, such as pug breed, are twenty times more prone to develop this condition. Although most of the cases are treated without surgical intervention, complicated and infected cases could lead to permanent blindness and other related complications. New approaches in treating this condition with mesenchymal stem cells (MSC) have been proposed with great results. Given their immunomodulation and regenerative properties, local administration of MSCs has proven to be safe and efficient in treating ocular related health conditions. This manuscript presents a complicated case of a canine CU treated with local infiltration of 1x106 canine dental pulp MSCs (cDMSCs). Stem cell therapy was performed at the Central Medica Veterinaria in Colima, Mexico with the consent of the owner, as it was hypothesized that the regenerative properties of MSCs could potentially alleviate the patient´s condition. Notorious improvement was reported after 12 hours of infiltration, and neovascularization process was observed within the next few days. The patient was discharged on the 29th day of treatment, with minimal scar and fully regain normal vision. Therefore, using MSCs is a viable option for treating corneal ulcers in dogs.
Keywords: Corneal Ulcer, Dogs, Mesenchymal Stem Cells, Regenerative Medicine.
